Maplight Therapeutics director Troy Cox reports purchase of 15,620 shares worth $148,702.4 - MPLT News | RalliesMaplight Therapeutics director Troy Cox reports purchase of 15,620 shares worth $148,702.4
M
MPLT• Director reports share purchase
- Maplight Therapeutics director Troy Cox reported buying 15,620 shares of voting common stock at a weighted average price of $9.52.
- The shares were held indirectly through a trust, lifting his trust-held stake to 15,620 shares.
- Cox also reported 7,864 shares held directly.
•
